PROCEPT BioRobotics (PRCT) CTO Barry Templin Sells 373 Shares

What Happened
Barry L. Templin, EVP and Chief Technology Officer of PROCEPT BioRobotics (PRCT), sold 373 shares on 2026-09-09 at $20.95 per share, generating proceeds of about $7,815. The sale was reported on a Form 4 filed 2026-09-10. This was a sale (not a purchase), and — per the footnote — part of a routine sell-to-cover to satisfy tax withholding tied to vested restricted stock units.

Key Details

• Transaction date and price: 2026-09-09 — 373 shares sold at $20.95 each.
• Total proceeds: approximately $7,815.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: sale executed pursuant to the issuer's sell-to-cover process to cover tax withholding for RSUs that vested on 2026-09-05. (Footnote F1)
• Timeliness: Form 4 was filed on 2026-09-10 for a 2026-09-09 transaction — no late filing indicated.

Context
Sell-to-cover transactions are common when restricted stock units vest and are used solely to pay tax withholding; they do not necessarily indicate the insider's view of the company's prospects. The transaction code is S (sale) with an F-style footnote indicating tax-withholding disposition.